The Drug Enforcement Administration on June 17 published an interim final rule placing two new drugs in Schedule IV (84 Fed. Reg. 27938, 27943) and on June 18 confirmed a pending interim rule listing a veterinary drug in Schedule II (84 Fed. Reg. 28212). Brexanolone and solriamfetol were scheduled following notification from the U.S. Food and Drug Administration that the drugs had ... Read More